Advertisement

Topics

BioDevelops Pharma GmbH Company Profile

23:29 EST 18th November 2017 | BioPortfolio

BioDevelops, an independent Austrian company, was initially founded back in 2002 and first concentrated on biomarker applications. Due to an opportunity to engage in the development of a clinical Phase II product with AOP Orphan Pharmaceuticals, the company changed its focus early in 2004 and entered the Cystic Fibrosis arena.Following successful turnaround, BioDevelops started its research operations a few months later at the Institute for Pharmacology in Vienna and focused on strategies for treatment of cystic fibrosis. In Sept. 2004, the Medical University of Vienna sold respective IP rights to BioDevelops. Consequently, the company filed a US-patent for an approach to enhance cell surface expression of proteins targeting Protein-Folding Diseases. The preliminary data - obtained with the A2A-receptor - were later supported with experimental findings on CFTR, the protein which is mutated in cystic fibrosis. The underlying research has been published recently (for full paper see T. Milojevic; for review see M. Toews). In addition to the IP transfer, the University granted to BioDevelops a right of first refusal for all IP related to the content of the original patent. Accordingly, BioDevelops also exerted its prerogative in sponsoring the July 2005 submission of a “second medical use” patent for proteasome inhibitors in the treatment of cystic fibrosis.

Location

c/o Institute for PharmacologyWaehringer Strasse 13A
Vienna
1090
Austria

Contact

Phone: 43.1.710.6616
Fax: 43.1.710.6614
Email: board@biodevelops.com


News Articles [703 Associated News Articles listed on BioPortfolio]

Körber Plans Takeover of Systec Services GmbH

     (Photo: http://mma.prnewswire.com/media/558312/SystecServices_Headquarters.jpg) With the planned takeover, Körber Medipak Systems GmbH, the holding company of Business Area Pharma Systems...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 12062017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 17102017] Prices from USD $350

Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Merz Pharma GmbH Co. KGaA Mergers Acquisitions MA, Partnerships Alliances and ...

Takeda options ADCs from Heidelberg Pharma

Heidelberg Pharma GMBH and Takeda Oncology (aka Millennium Pharmaceuticals) entered an agreement for the development and potential commercialization of antibody drug conjugates based on Heidelberg’s...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

Cosmos Holdings Signs Letter Of Intent To Acquire CC Pharma GmbH A Leading Re-Importer Of EU Pharmaceuticals To Germany

  Life Sciences Jobs   ...

Cosmos Holdings Signs Letter of Intent To Acquire CC Pharma GmbH A Leading Re-importer of EU Pharmaceuticals to Germany

CHICAGO, IL -- (Marketwired) -- 06/23/17 -- Cosmos Holdings, Inc. (the Company) (OTCQB: COSM), an international pharmaceutical company, announced today that it signed a new Letter of Intent (LOI) to ...

Cytovia grants Latin American Ceplene rights to Pint Pharma

Cytovia Inc., the oncology division of Immune Pharmaceuticals Inc., granted Pint Pharma GMBH rights to market and distribute Ceplene (histamine dihydrochloride) for acute myeloid leukemia in Latin Ame...

PubMed Articles [38 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials Series - Large Pharma.

AI-powered drug discovery captures pharma interest.

Arkansas execution proceeds as pharma companies lose battle to stop use of their drugs.

Clinical Trials [107 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

The purpose of this study is to confirm a significant influence of ezetimibe and sirolimus on each others pharmacokinetics

Fasting Bioequivalence Study of Memantinol 20 mg Tablets Versus Akatinol Memantine® 20 mg Tablets In Normal Healthy Subjects

This study are two-way crossover, open-label, single-dose, fasting, bioequivalence study of Memantinol® (JSC "GEROPHARM", Russia) 20 mg tablets versus Akatinol Memantine® (Merz Pharma Gm...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-lowering Ezetimibe and the Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4,

The purpose of this study is to evaluate the effects of a chronic co-medication of efavirenz on pharmacokinetics and sterol-lowering effects of ezetimibe at steady-state in healthy subject...

Companies [1214 Associated Companies listed on BioPortfolio]

BioDevelops Pharma GmbH

BioDevelops, an independent Austrian company, was initially founded back in 2002 and first concentrated on biomarker applications. Due to an opportunity to engage in the development of a clinical Phas...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

INJEX Pharma AG

INJEX Pharma Aktiengesellschaft and its subsidiaries INJEX Pharma GmbH and INJEX Vertrieb Deutschland GmbH are specialized in the development, manufacturing and marketing in the m...

CROMA-PHARMA GmbH

CROMA-PHARMA is a family owned, internationally orientated pharmaceutical company, based in Korneuburg, Austria. CROMA-PHARMA´s areas of activity are orthopedics, ophthalmology...

Ratiopharm

On June 29, 2000, ratiopharm GmbH, Europe's largest generic drug company, purchased Technilab Pharma to establish ratiopharm's generic operations in Canada. Long before being acquired by ratiopharm Gm...

More Information about "BioDevelops Pharma GmbH" on BioPortfolio

We have published hundreds of BioDevelops Pharma GmbH news stories on BioPortfolio along with dozens of BioDevelops Pharma GmbH Clinical Trials and PubMed Articles about BioDevelops Pharma GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioDevelops Pharma GmbH Companies in our database. You can also find out about relevant BioDevelops Pharma GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cystic Fibrosis
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record